Epidemiology of Legionnaires Disease in Europe Birgitta de Jong on behalf of ELDSNet ESGLI conference 22 September 2016

Similar documents
Annual Epidemiological Report

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Monthly measles and rubella monitoring report

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 SERBIA

Legionnaires disease in Europe

Vol. 18 Weekly issue June 2013

Where we stand in EFORT

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

Measles and rubella monitoring January 2015

Engagement in language assessment / Regions of Europe

Outbreak of travel-associated Legionnaires' disease Palmanova, Mallorca (Spain), September October Main conclusions and options for response

Main developments in past 24 hours

Shigellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Hepatitis A SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.

Q1 What age are you?

Smokefree Policies in Europe: Are we there yet?

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers

Giardiasis (lambliasis)

Overview of drug-induced deaths in Europe - What does the data tell us?

Alcohol-related harm in Europe and the WHO policy response

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

EUVAC.NET A surveillance network for vaccine-preventable diseases

Highly pathogenic avian influenza "The Epidemic" Regionalisation in the European Union

Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA

Recommended composition of influenza virus vaccines for use in the 2007 influenza season

EURO POLIO PAGE Data as of 04 October 2005 (Week 38)

European Collaboration on Dementia. Luxembourg, 13 December 2006

Summary. Primary care data. Week 49/2014. Season

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

Invasive meningococal diseasefocus on Meningococcal B - epidemiology, international and Ireland

Lymphogranuloma venereum

Highlighting in the WHO European Region:

Weekly Influenza Surveillance Report. Week 11

Weekly influenza surveillance overview

SURVEILLANCE REPORT. Surveillance of seven priority food- and waterborne diseases in the EU/EEA.

REVIEW OF THE ANALYSIS RELATED TO RABIES DIAGNOSIS AND FOLLOW-UP OF ORAL VACCINATION PERFORMED IN NRLS IN 2015

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance

Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010.

Terms and Conditions. VISA Global Customer Assistance Services

EU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 20 April 2017

CND UNGASS FOLLOW UP

Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous)

Tuberculosis Now! Jon S Friedland MA, FRCPE, FMedSci. Infectious Diseases & Immunity

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

Table 7.1 Summary information for lung cancer in Ireland,

European monthly measles monitoring (EMMO)

Emily J. Hadgkiss, 1 George A. Jelinek, 1,2 Tracey J. Weiland, 1,3 Naresh G. Pereira, 4 Claudia H. Marck, 1 and Dania M.

HPAI H5(N8) in Member States in poultry, captive and wild birds

Invasive meningococcal disease

European Status report on Alcohol and Health

European status report on alcohol and health Leadership, awareness and commitment

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist

Summary of Results for Laypersons

Syphilis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

LEBANON. WCPT COUNTRY PROFILE December 2018

COMMISSION OF THE EUROPEAN COMMUNITIES REPORT FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMENT

Cross Border Genetic Testing for Rare Diseases

The health economic landscape of cancer in Europe

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

Recommended composition of influenza virus vaccines for use in the influenza season

Annual epidemiological report 2014 food- and waterborne diseases and zoonoses

DENMARK. WCPT COUNTRY PROFILE December 2018

Design and Analysis of a Cancer Prevention Trial: Plans and Results. Matthew Somerville 09 November 2009

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers

Epidemiology of tuberculosis in Europe. Marieke J. van der Werf European Centre for Disease Prevention and Control Amsterdam, 22 September 2014

Appendix F: Test-Curriculum Matching Analysis

GERMANY. WCPT COUNTRY PROFILE December 2018

Table 9.1 Summary information for stomach cancer in Ireland,

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

European Community Pharmacy: a reference in Public Health

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

Primary and secondary prevention of sudden cardiac death in emerging economies

EUDY JUNIOR CAMP 2018 FIRST ANNOUNCEMENT

Global EHS Resource Center

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006

Allied Health: Sustainable Integrated Health Care for all Australians

11 Melanoma of the skin

MENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

Transcription:

Epidemiology of Legionnaires Disease in Europe 2015 Birgitta de Jong on behalf of ELDSNet ESGLI conference 22 September 2016

ELDSNet annual data set

Methods ECDC coordination Collection of disaggregate data through TESSy EU + Iceland and Norway (each country s own residents) Confirmed and probable cases of Legionnaires disease with onset in 2015 EU case definition

LD notification rate per 1,000,000 population EU/EEA, 1995 2015 14 12 10 n/million 8 6 4 2 0 Year 2015 has highest notification rate ever: 1.37 per 100,000 pop. 7034 cases reported by 30 countries 17% increase in total cases in last 2 years Continuous increase over the 2011 2015 period

Rate of confirmed Legionnaires disease cases per 100,000 pop. by country, EU/EEA, 2015 France, Germany, Italy and Spain reported 69% of all cases Denmark, France, Italy, Netherlands, Slovenia and Spain had agestandardised rates >2 cases per 100,000 pop.

Rate of Legionnaires disease cases per 100,000 population, by age and gender, EU/EEA, 2015 Rate per 100 000 population 6,0 5,0 4,0 3,0 2,0 1,0 0,0 Male Female 0 4 5 14 15 24 25 44 45 64 65 Age (year) 89% of cases aged 45 years and older Notification rate increased with age

Completeness of reporting for a selection of variables, EU/EEA, 2009 2015 100% Outcome Place of residence Setting 80% 60% 40% 20% 0% 2009 2010 2011 2012 2013 2014 2015 Completeness of place of residence and outcome are improving Completeness for setting is slightly decreasing

Number of confirmed Legionnaires disease cases by month, EU/EEA, 2015 and 2011 2014 Peak in August-September 59% of all cases reported from June to October

Number of confirmed Legionnaires disease cases by month and 12-month moving average, EU/EEA, 2011 2015 Steady increase over the 2011 2015 period

Cases by probable setting of infection, EU/EEA, 2015 Setting No. % Community-acquired 4227 69 Travel abroad 782 13 Domestic travel 548 9 Healthcare-associated 470 7 Other 117 2 Total 6144 100 Probable setting of infection comparable with previous years Proportion of healthcare-associated cases increases with age (4% below 50 years to 17% in cases aged 80 years+ )

Reported case-fatality by age group and sex, EU/EEA, 2015 40% 30% Case-fatality 20% Females Males 10% 0% 0-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89 90+ Age (years) Overall case-fatality of 8% Case fatality comparable between genders Steep increase of case fatality beyond 50 years old

Reported laboratory methods, EU/EEA, 2009 2015 15% Culture PCR Single high titre 10% 5% 0% 2009 2010 2011 2012 2013 2014 2015 89% of cases diagnosed by urinary antigen test (highest ever) Continuous increase of proportion of cases reported with a PCR

Reported pathogens, EU/EEA, 2015 Of 831 culture-confirmed cases o 796 (95%) were due to L. pneumophila o 679 (82%) were due to L. pneumophila serogroup 1 o 7 (0.8%) were due to L. longbeachae Of 173 SG1 isolates subtyped with monoclonal antibodies (MAb) o 43 (25%) Knoxville o 42 (24%) were Philadelphia o 29 (17%) Benidorm o 22 (13%) Allentown/France Distribution of pathogens comparable to previous years 80% L. pneumophila serogroup 1 MAb 3/1 positive

Conclusions In 2015, both number and notification of LD were the highest ever observed o Continuing the increase observed since 2011 o Contrary to 2014, no large outbreak o Main characteristics of the cases reported in 2015 similar to previous years o No increase was observed in countries with low notification rate An increasing trend affected by: o o o o Improved surveillance Ageing population Travel trends Climate (both 2014 and 2015 were the warmest years on record in Europe)

ECDC surveillance outputs http://atlas.ecdc.europa.eu/public/index.aspx?instance=generalatlas

ECDC surveillance outputs

TRAVEL ASSOCIATED LEGIONNAIRES DISEASE, 2015 Emmanuel Robesyn, Annual Meeting ELDSNet, London, 14-15 September 2014

Methods Daily reporting of disaggregate data through TESSy Confirmed and probable cases of Legionnaires disease with onset in 2015 and that had been travelling 2-10 days before onset of disease Reported by EU member states and ELDSNet contacts outside EU EU case definition

Number of TALD reports 1987 2015 Number of cases 1200 1000 800 600 400 200 0 1141 cases in 2015 (+ 20%) Year

Reported TALD cases, Europe, 2015

Non EU/EEA reporting countries 2014 2015 7 countries 21 cases 3 countries 38 cases Switzerland 10 Israel 4 USA 3 Andorra 1 New Zealand 1 Thailand 1 Turkey 1 Switzerland 30 USA 6 Australia 2

Median time to reporting = 17 days

Clinical outcome TALD, 2015 Status at time of reporting Number Percentage Outcome Number Percentage Known 611 54 % Unknown 530 46 % Total 1141 Died 26 4.3 % * Alive 585 95.7 % Total 611 * Case fatality rate (CFR) among cases with known outcomes

Number of test by laboratory method used (n=1215) Laboratory method Count % Urinary antigen test 1059 87 PCR 94 8 Culture 48 4 Single high level of Ab titre 11 <1 Significant rice in Ab titre 3 <1

Reported pathogens, TALD 2015 Of 1141 reported cases o 1074 (94%) were due to L. pneumophila o 770 (72%) were due to L. pneumophila serogroup 1 o 27 were due to L. pneumophila non-sg1 o 2 were due to L. pneumophila serogroup 3 o 2 were due to L. pneumophila serogroup 6 o 4 were due to L. pneumophila mixed serogroups o 1 were due to L. longbeachae Of 14 SG1 isolates subtyped with monoclonal antibodies (MAb) o 4 Knoxville o 2 Philadelphia o 6 Benidorm o 2 Allentown/France o 17 cases were reported to be sequenced, 3 cases has type 42 and 2 cases type 23

Travel visits of cases by destination country Destination country Number visits Percentage Italy 417 France 290 Spain 130 Germany 75 Greece 75 Turkey 71 United Kingdom 48 United States 45 United Arab Emirates 39 Thailand 37 Other 379 1606 26% 18% 8% 5% 5% 4% 3% 3% 2% 2% 24% 100%

Travel regions, TALD 2014 vs 2015 2014 # cases 2015 # cases EU / EEA 1000 1221 Outside EU 347 353 Ships 24 32 Total 1371 1606

Clusters 167 clusters notified 155 standard clusters 12 complex clusters Activity Form A submitted 178 Form B submitted 162 Summary report I Summary report II Number 409 associated cases (reported by 19 countries) Clusters in 33 countries, plus on board ships: 17 EU countries 16 non EU countries 3 ships 39 new + 16 updates 14 new + 8 updates 60% of accommodations sampled were reported positive according form B

Number of cluster per country (n=155, standard clusters) Cluster country count Italy 44 France 26 Spain 15 Turkey 9 Germany 8 Greece 8 Thailand 8 United Arab Emirates 6 Portugal 3 Ships 3 United States of America 3 Belgium 2 Hungary 2 Tunisia 2 Bulgaria 1 Cluster country count China 1 Croatia 1 Cuba 1 Guadeloupe 1 Ireland 1 Kosovo 1 Moldova 1 Philippines 1 Poland 1 Romania 1 Serbia 1 South Africa 1 Sweden 1 United Kingdom 1 Viet Nam 1

Reported TALD clusters, world wide, 2015

Reported TALD clusters, Europe, 2015

Eight accommodation sites published (2015) Paris, France - 31 March Riva del Garda, Italy - 24 June Napoli, Campania, Italy - 3 August Palermo, Sicily, Italy - 5 August Indre, France 6 August Aulla, Toscana, Italy - 20 August Trapani, Sicily, Italy 30 October Avignon, Vaucluse, France 12 October (compare to 0 in 2014, 2 in 2013, 1 in 2012)

Added value of European surveillance/eldsnet Proportion of clusters that could only have been detected through ELDSNet 60 % (=93/155) of the new standard clusters in 2015

Thanks to all reporters and investigators! ELDSNet team ECDC eldsnet@ecdc.europa.eu